<p>Usage and types of gender-affirming care (GAC) in all included transmasculine patients (n = 945) in the Stanford Research Repository. None of the gender-affirming treatments when analyzed in aggregate nor individually by treatment type was associated with acanthosis nigricans (AN). Univariate analysis comparing patients with versus without AN was conducted using Fisher’s exact test. All statistic tests are two-tailed. Odds ratios (ORs) were calculated using the Baptista-Pike method. P-values are between transmasculine patients with and without AN.</p>

Usage and types of gender-affirming care (GAC) in all included transmasculine patients (n = 945) in the Stanford Research Repository. None of the gender-affirming treatments when analyzed in aggregate nor individually by treatment type was associated with acanthosis nigricans (AN). Univariate analysis comparing patients with versus without AN was conducted using Fisher’s exact test. All statistic tests are two-tailed. Odds ratios (ORs) were calculated using the Baptista-Pike method. P-values are between transmasculine patients with and without AN.